Rakuten Medical Stock
Rakuten Medical is a biotechnology company focused on developing innovative cancer treatments through its proprietary Alluminox™ platform, which utilizes precision, cell-targeting photoimmunotherapy. The company aims to enhance cancer care by providing effective and accessible therapies, emphasizing its mission to "conquer cancer."
Sign up for SecondMarket™ to view the market and buy or sell Rakuten Medical Stock
Buy + SellRakuten Medical Funding
Sign up to gain insights into Rakuten Medical funding history, including the funding round, time period, and amount raised.
Sign Up to Unlock the Data| Date | Financing Round | Amount | Price per share* | Valuation* |
|---|---|---|---|---|
| Aug 14, 2023 | Series E | 73.69M | ||
| Aug 14, 2023 | Series E | 31.13M | ||
| Jul 16, 2021 | Series D | 166.01M | ||
| Dec 31, 2020 | Series C | 15.00M | ||
| Jul 01, 2020 | Series C | 791.70K | ||
| Jul 31, 2019 | Series C | 100.00M | ||
| Aug 10, 2018 | Series C | 150.00M | ||
| Jul 07, 2017 | Series B | 15.08M | ||
| Oct 05, 2016 | Series B | 15.20M | ||
| Feb 24, 2016 | Series B | 40.00M | ||
| Jul 17, 2015 | Series A | 4.25M | ||
| Dec 05, 2014 | Series A | 8.46M |
See Rakuten Medical Valuations + Financials
*Sample data + company shown for illustrative purposes only
Gain insights Into Rakuten Medical Stock Valuation + Share Prices
View real-time Tape D™ data on Rakuten Medical stock including most recent valuation and historical share price information.
Are you an institutional investor or employee shareholder? Sign up to the SecondMarket™ trading platform.
Get Started
Rakuten Medical Management Team
CSO, Director
Miguel Garcia-Guzman
President, Director
Takashi Toraishi
Director
Kentaro Hyakuno
Director
Hiroshi Takasawa
CEO, Director
Hiroshi Mikitani
COO, CFO
Brenton Keath
CTO
Carlos Garcia
Director
Nitin Nohria
Director
Hiroshi Mori
Director
David Chao
Rakuten Medical Major Investors
Rakuten Ventures
General Catalyst Partners LLC
SBI Holdings
